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Background: Just like diabetes, leprosy also cause painless neuropathic ulcers which process is 
mediated by Schwann-cell. Biochemical changes on leprosy patients presumed to have role on 
pathogenesis of diabetes mellitus.   
Methods: This study is cross-sectional study aimed to know further about diabetic status on 
population of people affected by leprosy, as the preliminary study to prove the association between 
diabetes mellitus and leprosy.  Data, such as diabetic status, type of leprosy, grade of disability, and 
other variables are collected from 127 people affected by leprosy in Donorojo leprosy recovered 
village.  
Result: Result showed that 19.7% are having diabetes mellitus, and other 23.6% are in pre-diabetic 
condition. This number is higher than prevalence of diabetes mellitus in Central Java (2.09%) and 
Indonesia (2%). 
Conclusion : Further research is needed to prove the association between leprosy and diabetic status.  
All leprosy patients should be recommended to be routinely screened for diabetes mellitus.  
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 Non-communicable diseases have been a 
health challenge, not only to high-income 
countries, but also the low-income countries.1 
71% of global deaths in 2016 are caused by 
non-communicable disease, and 3% of them 
are caused by diabetes. Global diabetes cases 
were increased for almost 4 folds, from 108 
million cases on 1980 to 422 million cases in 
2014.2  
In Indonesia, prevalence of diabetes was 
increasing, from 1,5% in 2013 to 2% in 2018.3 
Indonesia was the 7th country in the world with 
highest number of diabetes cases among people 
aged 20-79 years old, reaching 10.7 million 
cases of diabetes.4  
Diabetes is a chronic disease that occurs 
when pancreas can’t produce enough amount 
of insulin, or when the body can’t effectively 
use insulin that has been produced.3 Diabetes 
can cause damage to several organs, such as 
heart, blood vessels, eyes, kidney, nerves, and 
also cause complication, such as vision loss, 
stroke, heart attack, renal failure, even foot 
problems that lead to amputation if left 
untreated.2 Due to rapid increase of cases 
number and the complications it causes, 
diabetic is now become a priority in many 
countries.  
Just like diabetes, leprosy can also cause 
loss of sensation on the limbs, especially foot, 
increasing the risk of getting wound 
unconsciously.5 Both diabetes and leprosy are 
known of causing neuropathic ulcers which 
process is mediated by Schwann cell.6 
Biochemical changes on leprosy patients 
presumed to have role on pathogenesis of 
diabetes mellitus.7  
In 1979, survey of 120 people affected by 
leprosy in Jhansi, India showed that diabetes 
prevalence among people affected by leprosy 
(14.2%) is 7-folds higher than diabetes 
prevalence among normal population (2%).8 A 
cross-sectional study in Bangladesh showed 
that 4% among 3573 leprosy patients with 
disability are having diabetes.9 Case-control 
study in Kuwait in 2011 was also showing that 
diabetes incidence among cases group (people 
affected by leprosy) is higher than diabetes 
incidence among control group, with number 
of diabetes incidence reaching 13.3%, and 
37.7% among the cases group are in pre-
diabetic condition.7  
Until 2018, Indonesia is still on 3rd position, 
country with highest number of leprosy 
prevalence in the world, with number of 17.017 
cases.10 With the similar complications caused 
by diabetes and leprosy, people affected by 
leprosy with diabetes are having higher risk to 
encounter vision loss or neuropathic ulcers.  
Leprosy that mostly occurs among people 
with low-economic condition and strongly 
associated with stigma in society, causing lack 
of social support and resources for people 
affected by leprosy with diabetes to have 
further treatment.  
This study is aimed to know further about 
diabetic status on population of people affected 
by leprosy in Donorojo leprosy recovered 
village, as the preliminary study to prove the 
association between diabetes mellitus and 
leprosy.   
Methods 
Study Design 
This study is a cross-sectional study, carried 
out in 2019, in Donorojo leprosy recovered 
village Located in Jepara District, Central Java, 
Indonesia, to know number of diabetes 
prevalence among people affected by leprosy.  
Population and Sample 
Study population in this research is all 
people affected by leprosy that have finished 
their multi-drug therapy (MDT) treatment, that 
are living in Donorojo leprosy recovered 
village. Total sampling was used, so all study 
population who agreed to participate are all 
included in this research.  
There were total 138 people affected by 
leprosy that live in Donorojo leprosy recovered 
village and have finished MDT treatment. 
Amongst them, 3 persons were refused to have 
their capillary blood taken and 8 were out of 
village when data were collected, so only 127 
people affected by leprosy are included in this 
study as sample.  
Data Collection 
Data collection were carried out under 
permission of Donorojo Leprosy Hospital, the 
leprosy center hospital in Central Java. 
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Variables for which data were collected 
including history of leprosy (type of leprosy, 
duration of disease, duration of treatment, and 
leprosy reaction experience), disability grade, 
random blood sugar level, and other variables 
such as age, gender, and family history of 
diabetes. Data collected only from participants 
that agreed to informed consent paper.  
Data of diabetic status were collected 
through interview and measuring the blood 
sugar level. Participants that ever been 
diagnosed with diabetes by a doctor before will 
be grouped to subject with diabetes, although 
they showed normal level of blood sugar lever 
when measured. Blood sugar lever was 
measured by portable glucometer, and results 
will be classified based on World Health 
Organization’s criteria, in which subjects with 
random blood sugar level are greater than or 
equal to 11.1 mmol/L (200mg/dL) were 
addressed as diabetic.11 Consensus of Diabetes 
Management and Prevention applied in 
Indonesia is also stating that people with 
capillary random blood sugar level over or 
equal as 200 mg/dL are addressed as diabetic.12 
As for people with capillary random blood 
sugar level in between 140-200 mg are 
classified as people with impaired glucose 
tolerance, or in pre-diabetic condition. Pre-
diabetic subjects have a high risk of diabetes 
years in near future.11 Data about history of 
diabetes drugs consumption, change on 
lifestyle (diet, losing weight program, physical 
activities) was also collected from participants 
that ever been diagnosed with diabetes before.   
Data about history of affected by leprosy 
(type of leprosy, duration of disease, duration 
of treatment, and leprosy reaction experience), 
age, gender, and family history of diabetes 
were collected by interview and observation. 
Duration of disease is duration from the 
appearance of sign and symptom of leprosy 
until they got treated using MDT (months). 
Duration of treatment defined as duration of 
leprosy treatment using MDT measured in 
months. Type of leprosy was classified 
according WHO definition, to paucibacillary 




 127 from 138 people affected by leprosy 
that have finished the treatment and stated as 
release from treatment (RFT) in Donorojo 
leprosy recovered village were interviewed as 
participants. Participants consisted of 72 men 
(56.7%) and 55 women (43.3%), aged between 
23-81 years old with average 52 years old. 
From 127 participants, 62 have paucibacillary 
type (48.8%), and 65 have multibacillary type 
(51.2%).  
78 participants are (61.4%) having grade 2 
disabilities, based on WHO defined as visible 
deformity or damage presented. 18 participants 
(14.2%) are having grade 1 disabilities, in 
which anaesthesia present, but no visible 
deformity or damage, and the rest 31 
participants (24.4%) are having grade 0 
disabilities. Duration of disease, defined as 
duration from the appearance of sign and 
symptom of leprosy until they got treated using 
MDT, varied in range of 1 – 120 months with 
average of 37 months. As for duration of 
treatment, defined as duration of leprosy 
treatment using MDT, varied in range of 6-96 
months, with average of 25 months.  
Collected data are showing that 13 out of 
127 participants in this study have high random 
blood sugar level exceeding 200mg/dL, thereof 
classified as subjects with diabetes. 10 
participants that are having normal random 
blood sugar level when they were tested, and 
other 2 participants in pre-diabetic condition 
are also classified as subjects with diabetes, 
since they previously diagnosed with diabetes 
by doctor. Thus, in this study, we have total 25 
participants (19.7%) classified as subjects with 
diabetes.
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Table 1. Random blood sugar level of 
participants that previously have been 






































30 from 127 participants (23.6%) were 
having random blood sugar level in range 
of 140mg/dL-199mg/dL, therefore 
classified as subjects with pre-diabetic 
condition. All diabetic cases happen to 
people affected by leprosy aged > 45 years 
old, as for pre-diabetic condition are more 
commonly found in people affected by 
leprosy aged <45 years old(35.7%) than 
those who aged >45 years old (20.2%).  
Prevalence of diabetes is higher in men 
(22.2%) than in women (16.4%), so does 
with prevalence of pre-diabetic condition 
that is higher in men (27.8%) compared to 
prevalence of pre-diabetic condition in 
women (18.2%).  
Prevalence of diabetes is found higher 
in group of participants whose duration of 
disease is greater than or equal to 2 years 
and finished their treatment in 2 years or 
more. Prevalence of diabetes and pre-
diabetic condition is also commonly found 
in participants who previously has 
experienced leprosy reaction, compared to 
participants who never been experiencing 
leprosy reaction.  
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Treatment of leprosy is known to cause 
several effects, one of which is diabetes, 
induced by steroid consumption. 
Generally, blood sugar level will increase 
3 months since leprosy treatment using 
steroid is started. A study of 830 leprosy 
patients treated with steroid showed their 
high level of postprandial blood sugar 
level, varied between 230mg/dL to 
700mg/dL.13  
Several studies of people affected by 
leprosy, that have already finished their 
leprosy treatment are also showing higher 
prevalence of diabetes among people 
affected by leprosy compared to the 
general population. Study in Jhansi, Bihar, 
and Jharkhand, rural areas in India, 
showed that prevalence of diabetes in 
population of people affected by leprosy 
varied in range of 14.2% - 16.06%, so 
much higher than prevalence of diabetes in 
general population (2%). Study conducted 
in Kuwait is also showing that frequency 
of diabetes among leprosy patients is 
higher than control group (13.3% 
compared to 0%).8,14  
The high prevalence number of diabetes 
among people affected by leprosy can be 
attributed to some factors, one of which is 
the increasing level of stress hormones 
epinephrine, glucagon, and cortisone on 
people affected by leprosy that is well-
known to raise blood sugar level. 
Moreover, it is noted that people affected 
by leprosy tend to have higher pro- 
 
inflammatory cytokine TNF-α level 
than people on population of control 
group. TNF-α produce reactive nitrogen 
intermediate as protective agent against 
Mycobacteria and intracellular organism.  
On the other side, pro-inflammatory 
cytokine TNF-α plays specific role in 
regulation of insulin receptor signalling. 
Increasing pro-inflammatory cytokines 
TNF-α is-known to be associated with 
insulin resistance in several conditions, 
such as obesity, aging, and after muscle 
damage.7,8  
This study is also showed that 
prevalence of diabetes among population 
of people affected by leprosy in Donorojo 
leprosy recovered village pada is higher 
(19.7%) than general population in District 
of Jepara (3.13%), general population in 
Central Java Province (2.09%), and 
Indonesia (2%) in 2018.15,16 All diabetes 
cases in this study are happened on people 
affected by leprosy aged more than or 
equal to 45 years old.  
Furthermore, this study found that 30 
out of 127 participants are having impaired 
glucose tolerance or in pre-diabetic 
condition, with random blood sugar level 
in range of 140 mg/dL to 199 mg/dL.  
Prevalence of pre-diabetic condition 
tends to increase along with the aging of 
population. Aging process inducing the 
decrease of insulin sensitivity and 
alteration of pancreatic beta cell function 
resulting in insulin resistance.17 People 
aged more than 45 years old having the 
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highest risk to have impaired glucose 
tolerance.12  
In opposite with that, the result of this 
study showed that prevalence of pre-
diabetic condition is more commonly 
found among people affected by leprosy 
aged less than 45 years old (35.7%), than 
among them who aged 45 years old or 
more (20.2%).   
Increasing number of diabetes 
incidences is more likely to be happened 
among people with multibacillary type of 
leprosy. Research by Nigam et al (1979) 
and Saraya et al (2012) showed that 
impaired glucose tolerance incidences are 
found higher among people with 
multibacillary leprosy compared to the 
incidences among people with 
paucibacillary leprosy group and the 
control group.7,8  
In this study, prevalence number of 
diabetes in both group of people with 
multibacillary leprosy and paucibacillary 
leprosy are almost the same, but 
prevalence number of impaired glucose 
tolerance is found higher among people 
with multibacillary leprosy (30.8%) than 
the prevalence of impaired glucose 
tolerance among people with 
paucibacillary leprosy (16.1%). The high 
number of impaired glucose tolerance 
among people with multibacillary leprosy 
may be attributed to some factors such as 
infection severity, duration of infection 
and stress, which mainly catabolic in 
multibacillary leprosy, that is also an 
important cause of the development of 
impaired glucose tolerance.18  
Furthermore, duration of leprosy 
disease and duration of the treatment could 
also be the factors inducing diabetes to 
people affected by leprosy. Research of 43 
leprosy cases found that person whose 
duration of disease is at range of 0-6 
months tends to have normal glucose 
tolerance. Impaired glucose tolerance were 
found on person with duration of disease 
between 7-12 months, and the number 
grew high on group of people whose 
duration of disease are more than 2 
years.19   
Duration of leprosy treatment and 
leprosy reaction are also play a role on the 
development of impaired glucose 
tolerance. Multi drug therapy used in 
leprosy, and drugs used to treat leprosy 
reaction give effect on blood sugar level. 
Leprosy reaction is treated using systemic 
gluco-corticosteroid, that may cause 
steroid-induced diabetes mellitus, or 
worsen glycaemic condition of people 
affected by leprosy.20 Rifampicin, is one of 
drugs on multi drug therapy regimen that 
induce hepatic microsomal enzyme 
system, developing early phase of 
hyperglycaemia attributed to the 
augmented intestinal absorption.7,21 
This study found that diabetes is more 
likely to happen in person who has 
duration of disease and duration disease 
and duration of leprosy treatment more 
than 2 years. Impaired glucose tolerance is 
more common to be happened among 
people whose duration of disease and 
duration of treatment less than 2 years. 
More people who previously experienced 
leprosy reaction is having diabetes and 
impaired glucose tolerance compared to 
people who never experienced leprosy 
reaction before.  
In this study, participants are classified 
as people with diabetes if their random 
blood sugar level is found to be beyond 
200 mg/dL, or previously diagnosed with 
diabetes by a doctor.  Out of 25 persons 
classified as diabetic, data collected from 
this study showed 10 persons were having 
normal random blood sugar level and 2 
others indicated impaired glucose level. 
Normal blood sugar level on people with 
diabetes may be attributed to several 
factors, such as insulin therapy, diabetic 
drugs or herbal medicines consumption, 
specific diet, or routine physical activities. 
Proportion of participants who were 
receiving insulin therapy, consuming 
diabetic drugs or herbal medicines, doing 
specific diet and routine physical activity 
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after diagnosed with diabetes can be seen on Table 3.  
 
This study also showed that diabetes is 
more likely to be happened to people with 
grade 2 diabetes. Prevalence number of 
diabetes among people with grade 2 
disabilities (26.9%) is much higher than 
prevalence of diabetes among people with 
grade 1 disabilities (11.1%) and grade 0 
diabetes (6.5%).  
Diabetes, that is more likely to be 
happened among people with grade 2 
diabetes should be get special attention, 
notably related to prevention of wound, 
complication, and disability. Both leprosy 
and diabetes causing loss of sensation, 
mostly on feet, increasing risk of getting 
wound and ulceration. Furthermore, 
people affected by leprosy with diabetes 
are having higher risk to undergo tropic 
ulceration, neuro-osteoarthropathy, and 
vision loss. Moreover, low socioeconomic 
status, stigma and discrimination towards 
leprosy, and lack of social support that are 
often happen to people affected by leprosy 
could delay the wounds treatment to 
prevent further disabilities.  
Limitation of this study lies on small 
number of participants. Using total 
sampling, we could only recruit 127 
persons affected by leprosy as participants 
on this study, resulting on wide range of 
95% CI. Statistically difference in 
proportions of people with pre-diabetes 
condition can only be found on some 
variables, such as age group, type of 
leprosy, and duration of disease. As for 
Proportion of people with diabetes is 
proven to be statistically different in 
groups with different grades of disabilities, 
in which number of diabetes cases is found 
to be higher in group of grade 2 
disabilities, compared to grade 1 and 0.  
This study may be affected by recall 
bias, since data about history of affected 
by leprosy (type of leprosy, duration of 
disease, duration of treatment, and leprosy 
reaction experience), that happened in the 
past was collected using interview method. 
Thus, information regarding variable of 
exposure (history of leprosy) could not 
accurately describe conditions in 
population of people affected by leprosy.  
Conclusion 
Result of this study showed higher 
prevalence number of diabetes among 
population of people affected by leprosy. 
Diabetes is more likely to be happened to 
people with grade 2 disabilities. Diabetes 
on population of people affected by 
leprosy may cause further complication 
such as neuropathic ulcers, vision loss, and 
hindering the wounds treatment. Further 
research is needed to prove the association 
between leprosy and diabetes. Screening 
for diabetes is better to be routinely done 
in population of people affected by 
leprosy, to prevent further complication 
and disabilities.  
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Table 3. Factors attributed to blood sugar level among people previously diagnosed with diabetes 
(n=25) 
Random blood sugar 
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